DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Hodgkin's Lymphoma Forecast in 17 Major Markets 2016-2026" report to their offering.
Hodgkin's Lymphoma (HL) is a cancer (also known as Hodgkin Disease, Hodgkin Lymphoma or Hodgkin's Disease) of the lymphatic system and is one of two common types of cancers of the lymphatic system. The inclusion of Reed Sternberg cells, a type of white blood cell called a B lymphocyte, helps clinicians to delineate HL from other types of lymphoma.
Reasons to Buy:
- Able to quantify patient populations in global Hodgkin's Lymphoma market to target the development of future products, pricing strategies and launch plans.
- Gain further insights into the incidence of the subdivided types of Hodgkin's Lymphoma and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on Hodgkin's Lymphoma incident population.
- Identify sub-populations within Hodgkin's Lymphoma which require treatment.
- Gain an understanding of the specific markets that have the largest number of Hodgkin's Lymphoma patients.
Report Structure:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography/Ethnicity
6. Disease Prognosis & Clinical Course
7. Key comorbid conditions/Features associated with the disease
8. Methodology for quantification of patient numbers
9. Top-line incidence for Hodgkin's Lymphoma
10. Stages and systemic symptoms at diagnosis of Hodgkin's Lymphoma
11. Co-morbid conditions in Hodgkin's Lymphoma patients
12. Abbreviations used in the report
13. Patient-Based Offering
14. Online Pricing Data and Platforms
15. References
16. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/84sdpk/hodgkins
